JPWO2018219968A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2018219968A5
JPWO2018219968A5 JP2019566198A JP2019566198A JPWO2018219968A5 JP WO2018219968 A5 JPWO2018219968 A5 JP WO2018219968A5 JP 2019566198 A JP2019566198 A JP 2019566198A JP 2019566198 A JP2019566198 A JP 2019566198A JP WO2018219968 A5 JPWO2018219968 A5 JP WO2018219968A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
binding fragment
seq
sequence defined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019566198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020521490A5 (https=
JP2020521490A (ja
JP7460370B2 (ja
Publication date
Priority claimed from GBGB1708655.4A external-priority patent/GB201708655D0/en
Application filed filed Critical
Publication of JP2020521490A publication Critical patent/JP2020521490A/ja
Priority to JP2021141016A priority Critical patent/JP7560420B2/ja
Publication of JP2020521490A5 publication Critical patent/JP2020521490A5/ja
Publication of JPWO2018219968A5 publication Critical patent/JPWO2018219968A5/ja
Priority to JP2022109106A priority patent/JP7406593B2/ja
Application granted granted Critical
Publication of JP7460370B2 publication Critical patent/JP7460370B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019566198A 2017-05-31 2018-05-29 細胞培養方法 Active JP7460370B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021141016A JP7560420B2 (ja) 2017-05-31 2021-08-31 細胞培養方法
JP2022109106A JP7406593B2 (ja) 2017-05-31 2022-07-06 細胞培養方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1708655.4A GB201708655D0 (en) 2017-05-31 2017-05-31 Cell culture methods
GB1708655.4 2017-05-31
PCT/EP2018/064102 WO2018219968A1 (en) 2017-05-31 2018-05-29 Cell culture methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021141016A Division JP7560420B2 (ja) 2017-05-31 2021-08-31 細胞培養方法

Publications (4)

Publication Number Publication Date
JP2020521490A JP2020521490A (ja) 2020-07-27
JP2020521490A5 JP2020521490A5 (https=) 2022-06-16
JPWO2018219968A5 true JPWO2018219968A5 (https=) 2022-06-16
JP7460370B2 JP7460370B2 (ja) 2024-04-02

Family

ID=59270991

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019566198A Active JP7460370B2 (ja) 2017-05-31 2018-05-29 細胞培養方法
JP2021141016A Active JP7560420B2 (ja) 2017-05-31 2021-08-31 細胞培養方法
JP2022109106A Active JP7406593B2 (ja) 2017-05-31 2022-07-06 細胞培養方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021141016A Active JP7560420B2 (ja) 2017-05-31 2021-08-31 細胞培養方法
JP2022109106A Active JP7406593B2 (ja) 2017-05-31 2022-07-06 細胞培養方法

Country Status (21)

Country Link
US (3) US12077796B2 (https=)
EP (2) EP4397682A3 (https=)
JP (3) JP7460370B2 (https=)
KR (3) KR20240096888A (https=)
CN (2) CN110741077B (https=)
AU (2) AU2018276376C1 (https=)
BR (1) BR112019024390A2 (https=)
CA (1) CA3065661A1 (https=)
CL (1) CL2019003459A1 (https=)
CO (1) CO2019012871A2 (https=)
EA (1) EA201992828A1 (https=)
ES (1) ES2978394T3 (https=)
GB (1) GB201708655D0 (https=)
HR (1) HRP20240585T1 (https=)
HU (1) HUE066922T2 (https=)
IL (2) IL270880B2 (https=)
MX (1) MX2019014140A (https=)
MY (1) MY193535A (https=)
PL (1) PL3630946T3 (https=)
RU (2) RU2021128024A (https=)
WO (1) WO2018219968A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201708655D0 (en) * 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
JP2023554489A (ja) * 2020-12-22 2023-12-27 ノバルティス アーゲー 細胞培養中の分泌された組換え発現タンパク質中のシステイン残基の酸化レベルを低減するための方法
GB202105424D0 (en) * 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
WO2025262319A1 (en) 2024-06-21 2025-12-26 Boehringer Ingelheim International Gmbh Modifying blue color formation in bioprocesses

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US6048728A (en) 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
EP1482031B1 (en) 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
JP5290489B2 (ja) 2001-11-08 2013-09-18 アッヴィ・バイオセラピューティクス・インコーポレイテッド Ｉｇｇ抗体の安定な液体医薬製剤
ATE472597T2 (de) 2003-05-15 2010-07-15 Wyeth Llc Kontrollierte glukosezufuhr für tierzellkultur
TWI364458B (en) 2004-08-27 2012-05-21 Wyeth Res Ireland Ltd Production of tnfr-lg
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
TWI374935B (en) 2004-08-27 2012-10-21 Pfizer Ireland Pharmaceuticals Production of α-abeta
ES2538986T3 (es) * 2006-11-08 2015-06-25 Wyeth Llc Medios diseñados racionalmente para un cultivo celular
US8030027B2 (en) * 2008-04-29 2011-10-04 St. Jude Children's Research Hospital Method for enhancing recombinant antibody production
US8252557B2 (en) 2008-10-28 2012-08-28 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
SG185037A1 (en) 2010-04-26 2012-11-29 Novartis Ag Improved cell culture medium
AU2011246502B2 (en) 2010-04-26 2014-08-28 Novartis Ag Improved cell cultivation process
CN102653729B (zh) 2011-03-04 2014-07-16 上海赛金生物医药有限公司 一种用于中国仓鼠卵巢细胞的培养基
WO2012145682A1 (en) * 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
JP6265970B2 (ja) * 2012-03-26 2018-01-24 サノフイ 安定なＩｇＧ４に基づく結合剤の製剤
WO2013158275A1 (en) * 2012-04-20 2013-10-24 Abbvie Inc. Cell culture methods to reduce acidic species
US20130281355A1 (en) 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
GB201208370D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Antibodies
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
EP2968544A4 (en) * 2013-03-15 2016-10-12 Hoffmann La Roche CELL CULTURE MEDIA AND METHOD FOR PRODUCING ANTIBODY
BR112016027797A2 (pt) 2014-06-18 2017-10-31 Medimmune Llc métodos e meios de cultura de células compreendendo n-acetilcisteína
WO2016108765A1 (en) 2014-12-29 2016-07-07 Wirojpaisi Wanlop Engine combustion system oxygen efficiency enhancing device with raised electrical voltage and improved installation method
GB201508180D0 (en) * 2015-05-13 2015-06-24 Ucb Biopharma Sprl Antibodies
US11220668B2 (en) * 2016-04-28 2022-01-11 Merck Patent Gmbh Method for reducing the trisulfide level in proteins
GB201608323D0 (en) * 2016-05-12 2016-06-29 Ucb Biopharma Sprl Pharmaceutical compositions
CN106222129A (zh) 2016-07-29 2016-12-14 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
WO2018018613A1 (zh) * 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods

Similar Documents

Publication Publication Date Title
AR040046A1 (es) Anticuerpo neutralizante humano anti-igfr
HRP20110187T1 (hr) Multispecifične deimunizirane tvari koje vežu cd3
JP2019193643A (ja) 細胞培養培地及び抗体を産生する方法
JP2020537520A5 (https=)
JP2021503938A5 (https=)
JP7560420B2 (ja) 細胞培養方法
CN111417715B (zh) 细胞培养方法
JP2021094022A5 (https=)
JP2021185185A5 (https=)
JPWO2018219968A5 (https=)
CN118852428A (zh) 抗EGFR抗体的生产方法、对于FcγRIIIa的亲和性提升方法及抗EGFR抗体
JPWO2023086817A5 (https=)
JPWO2023078382A5 (https=)
RU2026105457A (ru) Антитела к белку а-бета, способы и их применения
RU2024139604A (ru) Антитела к bcma
CN119060185A (zh) 一种调节抗体糖基化的方法
CN115505561A (zh) 一种用于cho细胞的无血清培养基添加剂及其用途
JPWO2021214277A5 (https=)
JPWO2023111128A5 (https=)
RU2009148270A (ru) Молекулы антител человека к il-13
JPWO2023016826A5 (https=)
JPWO2021108447A5 (https=)